Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Genome-wide Association Studies-GWAS01:11

Genome-wide Association Studies-GWAS

Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
Genetic Screens02:46

Genetic Screens

Genetic screens are tools used to identify genes and mutations responsible for phenotypes of interest. Genetic screens help identify individuals or a group of people at risk of developing  genetic diseases and help them with early intervention, targeted therapy, and reproductive options.
Forward genetic screens
Forward or “classical” genetic screens involve creating random mutations in an organism’s DNA using radiation, mutagens, or insertion of additional bases, which result in visible changes...
Single Nucleotide Polymorphisms-SNPs01:05

Single Nucleotide Polymorphisms-SNPs

A single nucleotide polymorphism or SNP is a single nucleotide variation at a specific genomic position in a large population. It is the most prevalent type of sequence variation found in the human genome. Point mutations that occur in more than 1% of the population qualify as SNPs. These are present once every 1000 nucleotides on an average in the human genome. Replacement of a purine with another purine (A/G) or a pyrimidine with another pyrimidine (C/T) is known as a transition. In contrast,...
Comparing Copy Number Variations and SNPs02:26

Comparing Copy Number Variations and SNPs

Sequencing of the human genome has opened up several best-kept secrets of the genome. Scientists have identified thousands of genome variations that exist within a population. These variations can be a single nucleotide or a larger chromosomal variation.
Copy number variations or CNVs are the structural variations that cover more than 1kb of DNA sequence. The single nucleotide polymorphism (SNP), on the other hand, is a single nucleotide change or a point mutation that is found in more than 1%...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Incidence and Severity of Postacute Sequelae of SARS-CoV-2 Infection in the Omicron Era: A Prospective Cohort Study.

The Journal of infectious diseases·2026
Same author

Durability of 2024-2025 COVID-19 Vaccines Against JN.1 Subvariants.

JAMA internal medicine·2025
Same author

Hypothesis Tests of Indirect Effects for Multiple Mediators.

Statistical methods & applications·2025
Same author

SEMIPARAMETRIC LINEAR REGRESSION WITH AN INTERVAL-CENSORED COVARIATE IN THE ATHEROSCLEROSIS RISK IN COMMUNITIES STUDY.

The annals of applied statistics·2025
Same author

Modeling 5-Year Hepatocellular Carcinoma Risk in Alaska Native Peoples With Hepatitis B Virus Infection.

Gastro hep advances·2025
Same author

HCC surveillance in hepatitis C: A longitudinal algorithm improves alpha-fetoprotein screening.

Hepatology communications·2025
Same journal

conMItion: an R package adjusting confounding factors for associations in multi-omics.

Bioinformatics (Oxford, England)·2026
Same journal

SpaMFG: a Spatial Multi-omics Integration Method based on Feature Grouping.

Bioinformatics (Oxford, England)·2026
Same journal

CSCN: Inference of Cell-Specific Causal Networks Using Single-Cell RNA-Seq Data.

Bioinformatics (Oxford, England)·2026
Same journal

Sparse CCA-Based Mediation Analysis with High-Dimensional Exposures and Mediators.

Bioinformatics (Oxford, England)·2026
Same journal

Enhancing Cross-Context Generalization in Drug Perturbation Prediction with a Multimodal Conditional Diffusion Framework.

Bioinformatics (Oxford, England)·2026
Same journal

Primer Design through Submodular Function Estimation.

Bioinformatics (Oxford, England)·2026
See all related articles

Related Experiment Video

Updated: Jun 7, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

A variable selection method for genome-wide association studies.

Qianchuan He1, Dan-Yu Lin

  • 1Department of Biostatistics, University of North Carolina, Chapel Hill, NC 27599, USA.

Bioinformatics (Oxford, England)
|November 2, 2010
PubMed
Summary
This summary is machine-generated.

GWASelect enhances genome-wide association studies (GWAS) by identifying multiple causal single nucleotide polymorphisms (SNPs) more effectively. This method improves disease risk prediction and reduces false discoveries in complex genetic analyses.

More Related Videos

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

Related Experiment Videos

Last Updated: Jun 7, 2026

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)
11:35

Screening for Functional Non-coding Genetic Variants Using Electrophoretic Mobility Shift Assay (EMSA) and DNA-affinity Precipitation Assay (DAPA)

Published on: August 21, 2016

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization
08:27

Large-Scale Multi-Omics Genome-Wide Association Studies (Mo-GWAS): Guidelines for Sample Preparation and Normalization

Published on: July 27, 2021

Area of Science:

  • Genetics
  • Bioinformatics
  • Statistical Genomics

Background:

  • Genome-wide association studies (GWAS) analyze millions of single nucleotide polymorphisms (SNPs) for complex disease insights.
  • Current single-SNP analysis methods in GWAS are limited, missing multiple causal variants and accurate disease risk prediction.
  • Existing joint analysis methods for GWAS data suffer from high false discovery rates (FDR) and miss marginally uncorrelated causal SNPs.

Purpose of the Study:

  • To introduce GWASelect, a novel variable selection method for GWAS data.
  • To address the limitations of existing GWAS analysis methods in identifying causal variants and predicting disease risk.
  • To develop a statistically powerful and computationally efficient tool for complex disease genetic dissection.

Main Methods:

  • GWASelect employs iterative SNP selection, considering conditional dependencies between SNPs.
  • A resampling mechanism is integrated to minimize false positive findings.
  • The method is designed to capture causal SNPs regardless of their marginal correlation with the disease.

Main Results:

  • GWASelect demonstrates superior power in identifying causal variants compared to existing methods across various linkage disequilibrium patterns.
  • The method achieves a lower false discovery rate (FDR) than traditional approaches.
  • Regression models utilizing GWASelect provide more accurate disease risk predictions, as validated with WTCCC data.

Conclusions:

  • GWASelect offers a statistically robust and computationally efficient approach for analyzing GWAS data.
  • The method significantly improves the identification of causal variants and disease risk prediction in complex genetic studies.
  • GWASelect represents a substantial advancement in leveraging the full potential of large-scale GWAS datasets.